Loading company…
Resolve BioSciences develops spatial analysis technology for life sciences research.
Resolve BioSciences develops Molecular Cartography, a platform for highly multiplexed spatial analysis in fields including oncology, neuroscience and infectious disease. It serves research institutions, biotechnology companies and pharmaceutical firms. In August 2022, the company raised USD 71.00 mn in Series B funding led by Patient Square Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in